Literature DB >> 12192036

Fer kinase is required for sustained p38 kinase activation and maximal chemotaxis of activated mast cells.

Andrew W B Craig1, Peter A Greer.   

Abstract

Mast cells play important roles in inflammation and immunity and express the high-affinity immunoglobulin E receptor (Fc epsilon RI) and the receptor protein-tyrosine kinase Kit. Aggregation of Fc epsilon RI via antigen binding elicits signals leading to the release of preformed inflammatory mediators as well as de novo-synthesized lipid mediators and cytokines and to elevated cell adhesion and migration. Here, we report that in mouse bone marrow-derived mast cells, Fer kinase is activated downstream of activated Fc epsilon RI and activated Kit receptor, and this activation is abolished in cells homozygous for a kinase-inactivating mutation in Fer (fer(DR/DR)). Interestingly, the highly related Fps/Fes kinase is also activated upon Fc epsilon RI aggregation. This report represents the first description of a common signaling pathway activating Fer and Fps/Fes. While Fer-deficient cells showed similar activation of the Erk mitogen-activated protein (MAP) kinases, p38 MAP kinase activation was less sustained than that in wild-type cells. Although no major defects were observed in degranulation, leukotriene biosynthesis, and cytokine secretion, Fer-deficient cells displayed increased adhesion and decreased motility upon activation of Fc epsilon RI and the Kit receptor. The restoration of Fer kinase activity in fer(DR/DR) mast cells resulted in prolonged p38 kinase activation and increased antigen-mediated cell migration of sensitized mast cells. Thus, Fer is required for maximal p38 kinase activation to promote the chemotaxis of activated mast cells. Further studies with mast cells derived from fps/fes-deficient mice will be required to provide insight into the role of Fps/Fes in mast cell activation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12192036      PMCID: PMC135645          DOI: 10.1128/MCB.22.18.6363-6374.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  65 in total

Review 1.  The juxtamembrane domain of cadherin regulates integrin-mediated adhesion and neurite outgrowth.

Authors:  J Lilien; C Arregui; H Li; J Balsamo
Journal:  J Neurosci Res       Date:  1999-12-15       Impact factor: 4.164

2.  Disruption of coiled-coil domains in Fer protein-tyrosine kinase abolishes trimerization but not kinase activation.

Authors:  A W Craig; R Zirngibl; P Greer
Journal:  J Biol Chem       Date:  1999-07-09       Impact factor: 5.157

3.  Cdc42-interacting protein 4 mediates binding of the Wiskott-Aldrich syndrome protein to microtubules.

Authors:  L Tian; D L Nelson; D M Stewart
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

4.  Mutation of a highly conserved aspartate residue in subdomain IX abolishes Fer protein-tyrosine kinase activity.

Authors:  L A Cole; R Zirngibl; A W Craig; Z Jia; P Greer
Journal:  Protein Eng       Date:  1999-02

5.  Cell cycle-dependent nuclear accumulation of the p94fer tyrosine kinase is regulated by its NH2 terminus and is affected by kinase domain integrity and ATP binding.

Authors:  I Ben-Dor; O Bern; T Tennenbaum; U Nir
Journal:  Cell Growth Differ       Date:  1999-02

Review 6.  The c-Fes family of protein-tyrosine kinases.

Authors:  T E Smithgall; J A Rogers; K L Peters; J Li; S D Briggs; J M Lionberger; H Cheng; A Shibata; B Scholtz; S Schreiner; N Dunham
Journal:  Crit Rev Oncog       Date:  1998

7.  Targeted disruption of the murine fps/fes proto-oncogene reveals that Fps/Fes kinase activity is dispensable for hematopoiesis.

Authors:  Y Senis; R Zirngibl; J McVeigh; A Haman; T Hoang; P A Greer
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

8.  SLP-76 deficiency impairs signaling via the high-affinity IgE receptor in mast cells.

Authors:  V I Pivniouk; T R Martin; J M Lu-Kuo; H R Katz; H C Oettgen; R S Geha
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

9.  Characterization of the EMS1 gene and its product, human Cortactin.

Authors:  E Schuuring; H van Damme; E Schuuring-Scholtes; E Verhoeven; R Michalides; E Geelen; C de Boer; H Brok; V van Buuren; P Kluin
Journal:  Cell Adhes Commun       Date:  1998

10.  Mitogen-activated protein kinase activation through Fc epsilon receptor I and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells.

Authors:  T Ishizuka; K Chayama; K Takeda; E Hamelmann; N Terada; G M Keller; G L Johnson; E W Gelfand
Journal:  J Immunol       Date:  1999-02-15       Impact factor: 5.422

View more
  23 in total

1.  Involvement of Fyn kinase in Kit and integrin-mediated Rac activation, cytoskeletal reorganization, and chemotaxis of mast cells.

Authors:  Lionel A Samayawardhena; Reuben Kapur; Andrew W B Craig
Journal:  Blood       Date:  2007-01-09       Impact factor: 22.113

2.  Absence of Fer protein tyrosine kinase exacerbates endotoxin induced intestinal epithelial barrier dysfunction in vivo.

Authors:  W Qi; K V J Ebbert; A W B Craig; P A Greer; D-M McCafferty
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

3.  Fes tyrosine kinase expression in the tumor niche correlates with enhanced tumor growth, angiogenesis, circulating tumor cells, metastasis, and infiltrating macrophages.

Authors:  Shengnan Zhang; Violeta Chitu; E Richard Stanley; Bruce E Elliott; Peter A Greer
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

4.  Identification of Fer tyrosine kinase localized on microtubules as a platelet endothelial cell adhesion molecule-1 phosphorylating kinase in vascular endothelial cells.

Authors:  Naoko Kogata; Michitaka Masuda; Yuji Kamioka; Akiko Yamagishi; Akira Endo; Masato Okada; Naoki Mochizuki
Journal:  Mol Biol Cell       Date:  2003-06-13       Impact factor: 4.138

5.  The Fer tyrosine kinase is important for platelet-derived growth factor-BB-induced signal transducer and activator of transcription 3 (STAT3) protein phosphorylation, colony formation in soft agar, and tumor growth in vivo.

Authors:  Johan Lennartsson; Haisha Ma; Piotr Wardega; Karin Pelka; Ulla Engström; Carina Hellberg; Carl-Henrik Heldin
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

6.  Fer kinase limits neutrophil chemotaxis toward end target chemoattractants.

Authors:  Maitham Khajah; Graciela Andonegui; Ronald Chan; Andrew W Craig; Peter A Greer; Donna-Marie McCafferty
Journal:  J Immunol       Date:  2013-01-25       Impact factor: 5.422

7.  SHP2 phosphatase promotes mast cell chemotaxis toward stem cell factor via enhancing activation of the Lyn/Vav/Rac signaling axis.

Authors:  Namit Sharma; Stephanie Everingham; Baskar Ramdas; Reuben Kapur; Andrew W B Craig
Journal:  J Immunol       Date:  2014-04-14       Impact factor: 5.422

8.  Detection of novel paraja ring finger 2-fer tyrosine kinase mRNA chimeras is associated with poor postoperative prognosis in non-small cell lung cancer.

Authors:  Masanori Kawakami; Rie Ishikawa; Yosuke Amano; Mitsuhiro Sunohara; Kousuke Watanabe; Nobuya Ohishi; Yutaka Yatomi; Jun Nakajima; Masashi Fukayama; Takahide Nagase; Daiya Takai
Journal:  Cancer Sci       Date:  2013-09-05       Impact factor: 6.716

9.  The tyrosine kinase FER is responsible for the capacitation-associated increase in tyrosine phosphorylation in murine sperm.

Authors:  Antonio Alvau; Maria Agustina Battistone; Maria Gracia Gervasi; Felipe A Navarrete; Xinran Xu; Claudia Sánchez-Cárdenas; Jose Luis De la Vega-Beltran; Vanina G Da Ros; Peter A Greer; Alberto Darszon; Diego Krapf; Ana Maria Salicioni; Patricia S Cuasnicu; Pablo E Visconti
Journal:  Development       Date:  2016-05-25       Impact factor: 6.868

10.  FER overexpression is associated with poor postoperative prognosis and cancer-cell survival in non-small cell lung cancer.

Authors:  Masanori Kawakami; Shigeki Morita; Mitsuhiro Sunohara; Yosuke Amano; Rie Ishikawa; Kousuke Watanabe; Emi Hamano; Nobuya Ohishi; Jun Nakajima; Yutaka Yatomi; Takahide Nagase; Masashi Fukayama; Daiya Takai
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.